Trevena, Inc. (TRVN)
OTCMKTS · Delayed Price · Currency is USD
0.0111
0.00 (0.00%)
Jul 20, 2026, 12:37 PM EST
Trevena Market Cap
Trevena has a market cap or net worth of $10.64 thousand as of July 31, 2026. Its market cap has decreased by -98.78% in one year.
Market Cap
10.64K
Enterprise Value
n/a
Revenue
546.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
ChartMarket Cap Chart
Since January 31, 2014, Trevena's market cap has decreased from 167.27M to 10.64K, a decrease of -99.99%. That is a compound annual growth rate of -53.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 10.64K | -7.49% |
| Dec 31, 2025 | 11.51K | -99.11% |
| Dec 31, 2024 | 1.30M | -88.18% |
| Dec 29, 2023 | 10.96M | -0.67% |
| Dec 30, 2022 | 11.03M | -88.49% |
| Dec 31, 2021 | 95.83M | -71.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regenicin | 15.35K |
| IO Biotech | 14.39K |
| NanoLogix | 13.03K |
| ObsEva | 11.72K |
| Biostax | 10.77K |
| Syros Pharmaceuticals | 10.73K |
| GeneLink | 10.60K |
| Windtree Therapeutics | 9.00K |